Hormone Replacement Therapy in Lighthouse Point: 4 Hormones Tested and Addressed

Hormone replacement therapy is a medical protocol that restores declining estrogen, progesterone, and/or testosterone levels in women experiencing perimenopause, menopause, or hormonal imbalance through bioidentical or synthetic hormone supplementation.

HRT is not a cosmetic service. It is a clinical intervention with decades of research behind it, a defined patient population, specific lab markers that guide prescribing, and a monitoring protocol that continues throughout the course of treatment. At Rebuild Regen Medical Clinic, no hormone protocol starts before bloodwork confirms the clinical indication. Elizabeth Celestin, APRN, FNP-C, orders a complete hormone panel at or before the first appointment and builds the protocol from those numbers, not from a symptom checklist alone.

For women in their 40s and 50s experiencing the full spectrum of perimenopausal and menopausal symptoms — sleep disruption, mood instability, hot flashes, brain fog, joint pain, low libido, vaginal dryness, weight redistribution — the conversation about HRT is worth having with a provider who understands both the clinical evidence and the individual patient picture. Elizabeth's background in emergency and trauma medicine means she approaches hormonal assessment as a diagnostician, looking at the full picture before recommending an intervention.

What HRT Is — Definition, Hormone Types, Why Levels Decline

Hormone replacement therapy works by supplementing hormones that the body no longer produces in sufficient quantity. In women, the relevant hormones are:

Estrogen: The primary female sex hormone, produced primarily in the ovaries. Estrogen regulates the menstrual cycle, maintains bone density, supports cardiovascular health, influences mood and cognition, and maintains the integrity of vaginal and urinary tissue. Ovarian estrogen production declines significantly during perimenopause and ceases almost entirely after menopause.

Progesterone: Produced in the ovaries and (during pregnancy) the placenta. Progesterone counterbalances estrogen's proliferative effects on the uterine lining and plays a role in mood regulation, sleep quality, and bone health. In women who have an intact uterus and are receiving estrogen therapy, progesterone is required to protect against estrogen-driven endometrial overgrowth.

Testosterone: Often associated primarily with male physiology, testosterone in women plays a critical role in libido, energy, muscle maintenance, cognitive sharpness, and mood. Female testosterone levels decline through the 30s and 40s. Low testosterone in women is frequently underdiagnosed and underaddressed.

DHEA: A precursor adrenal hormone that the body converts into estrogen and testosterone. DHEA levels decline with age and can be relevant in the hormonal picture, particularly for libido and energy.

The decline in these hormones during perimenopause is not uniform — it is variable, non-linear, and individual. Some women experience symptom onset in their early 40s with regular cycles still intact. Others reach menopause with minimal symptoms. The lab panel tells the clinical story that symptoms alone cannot.

Perimenopause vs. Menopause — Symptoms, Lab Markers, What Triggers Intervention

Perimenopause begins when ovarian function starts to fluctuate, typically in the 40s, and ends with the last menstrual period. Menopause is defined as 12 consecutive months without a menstrual period. Postmenopause is the phase that follows.

Clinically, the distinction matters because the hormonal pattern differs:

Perimenopause: Estrogen levels fluctuate erratically (not simply declining). Progesterone declines first. FSH (follicle-stimulating hormone) begins to rise as the pituitary compensates for declining ovarian response. Cycles may be irregular — longer, shorter, heavier, or lighter. Symptoms are highly variable.

Menopause: Estrogen declines to a consistently low level. FSH is elevated. LH (luteinizing hormone) is elevated. The hormonal milieu is fundamentally different from reproductive-age levels.

Lab markers Elizabeth evaluates:

Estradiol (E2) — primary estrogen form
Progesterone — timed to cycle phase if applicable
Total and free testosterone
FSH and LH
DHEA-S
Thyroid panel (TSH, free T3, free T4) — thyroid dysfunction mimics many menopausal symptoms
Comprehensive metabolic panel — baseline before any hormonal intervention

The trigger for HRT intervention is not a specific number in isolation — it is the combination of lab findings and the patient's symptom burden. A woman with low-normal estradiol and significant symptomatic impact is a different clinical picture than a woman with the same number and no symptoms. Elizabeth evaluates both dimensions before recommending a protocol.

Delivery Methods — Pellet, Injection, Topical, Oral

Hormone delivery method matters because it affects hormone stability, dosing precision, patient compliance, and specific risks associated with different forms of estrogen delivery.

Bioidentical hormone pellets: Small pellets containing crystallized bioidentical hormones (estradiol, testosterone, or both) implanted subcutaneously in the hip or buttocks under local anesthesia. Pellets release hormones steadily over 3 to 5 months, mimicking the body's natural continuous secretion pattern. This avoids the peaks and troughs associated with other delivery methods and eliminates the daily compliance requirement. Elizabeth uses bioidentical pellets for many of her HRT patients because of this stability advantage.

Injections: Estrogen and testosterone in injectable form, administered intramuscularly or subcutaneously on a set schedule (weekly, biweekly, or monthly depending on the compound). Injections allow precise dose control and can be adjusted easily. Some patients prefer this method for the control it provides.

Topical creams and gels: Applied daily to specific skin sites for transdermal absorption. Topical estrogen and testosterone are convenient and produce consistent levels in compliant patients. Transdermal estrogen has a favorable cardiovascular risk profile compared to oral forms.

Oral: Oral progesterone (bioidentical, such as micronized progesterone) is commonly used for its sleep-supporting effects. Oral estrogen is used in some protocols but is not Elizabeth's first-line choice due to first-pass liver metabolism and the associated elevation in clotting factors.

Elizabeth selects the delivery method based on the patient's lab picture, symptom profile, lifestyle, and preference. There is no single "right" delivery method for all patients.

The Process — Consultation, Labs, Protocol, Monitoring

HRT at Rebuild Regen follows a defined clinical sequence:

1. Initial consultation: Elizabeth reviews your symptom history, menstrual pattern, prior hormone use, family history, cardiovascular history, and personal health goals. She explains the hormone panel she will order and what the results will tell her.

2. Lab work: A full hormone panel plus baseline metabolic labs is ordered. Results typically return within 2 to 5 business days. Elizabeth reviews the panel and contacts you with findings.

3. Protocol design: Based on lab findings and symptom picture, Elizabeth designs your initial protocol — hormones to address, delivery method, starting dose, and monitoring schedule. For pellet insertion, a separate brief procedure visit is scheduled.

4. Treatment and monitoring: Hormone levels are rechecked at 4 to 6 weeks for injectable and topical methods, or at 3 months for pellet protocols. Doses are adjusted based on follow-up lab values and symptom response. Ongoing monitoring is standard.

5. Ongoing optimization: HRT is not a "start and stop" treatment. It is a managed ongoing protocol. Elizabeth conducts comprehensive reviews at least annually and adjusts protocols as clinical needs change over time.

Is Hormone Replacement Therapy the Right Choice for Your Symptoms?

HRT is appropriate for women with documented hormonal decline accompanied by quality-of-life symptoms that affect daily function. It is particularly relevant for women who experience sleep disruption, cognitive changes, mood instability, vasomotor symptoms (hot flashes, night sweats), genitourinary symptoms, joint pain, or libido changes that correlate with the perimenopausal or menopausal transition.

HRT is not appropriate as a first step before labs are reviewed. Elizabeth will not prescribe hormone therapy without lab confirmation of the clinical indication. If your labs show levels within optimal ranges and symptoms persist, the investigation turns to other causes — thyroid function, adrenal health, sleep quality, nutritional status — before a hormonal prescription is written.

Frequently Asked Questions

Does HRT carry cancer risk?

The relationship between HRT and breast cancer risk has been studied extensively and re-evaluated significantly since the 2002 Women's Health Initiative study. Current evidence indicates that bioidentical progesterone has a more favorable risk profile than synthetic progestins used in that study. Estrogen-only therapy in women without a uterus does not appear to increase breast cancer risk. For women with specific risk factors, the risk-benefit calculation is part of the consultation. Elizabeth reviews your personal and family history before prescribing any hormone therapy.

How quickly does HRT work?

Hormone therapy response varies by symptom and delivery method. Hot flash reduction is often among the fastest improvements, sometimes within 2 to 4 weeks. Cognitive and mood effects may take 6 to 8 weeks. Bone and cardiovascular benefit accumulates over months. Sleep quality often improves early in the protocol.

What is the difference between bioidentical and synthetic hormones?

Bioidentical hormones are chemically identical to the hormones produced by the human body. Synthetic hormones have similar but not identical molecular structures. At Rebuild Regen, Elizabeth uses bioidentical hormone preparations (including pellets, micronized progesterone, and bioidentical estradiol) based on the evidence supporting their physiological compatibility and risk profile.

Is HRT safe long-term?

Long-term HRT safety depends on the type of hormone, the delivery method, the patient's individual risk factors, and ongoing monitoring. Elizabeth reviews this question specifically during your consultation and does not apply a blanket answer. The goal is an individualized risk-benefit assessment, not a policy position.

Can testosterone be part of a female HRT protocol?

Testosterone is an established component of female HRT when lab values confirm deficiency and symptoms support the clinical indication. Low testosterone in women is associated with reduced libido, fatigue, cognitive decline, and muscle loss. Elizabeth addresses testosterone as part of the full hormonal picture when indicated.

When HRT Is Contraindicated

HRT is contraindicated in women with a current or recent diagnosis of hormone-sensitive cancers (estrogen receptor-positive breast cancer, endometrial cancer), undiagnosed vaginal bleeding, active or recent thromboembolic events (deep vein thrombosis, pulmonary embolism), severe liver disease, or untreated cardiovascular disease. Patients with any of these conditions require specialist evaluation before any hormone protocol is considered. Elizabeth identifies contraindications during the consultation and refers appropriately.

Rebuild Regen Medical Clinic 3320 N Federal Hwy #101, Lighthouse Point, FL 33064 (954) 953-4208 | rebuildregenmedical.com

Schedule an HRT Consultation | Testosterone Replacement Therapy for Men